Meyka Pro banner
AnGes, Inc.

AnGes, Inc. Fundamental Analysis (JPX: 4563.T)

4563.TJPX
HealthcareBiotechnology
¥39.00
¥0.00(0.00%)
Japanese Market opens in 10h 53m

AnGes, Inc. Fundamental Analysis (JPX: 4563.T)

AnGes, Inc. (JPX: 4563.T) shows moderate financial fundamentals with a PE ratio of -4.09, profit margin of -4.02%, and ROE of -1.63%. The company generates $1.0B in annual revenue with strong year-over-year growth of 35.94%.

Key Strengths

PEG Ratio-0.02

Areas of Concern

ROE-1.63%
Operating Margin-6.22%
Cash Position1.91%
Current Ratio0.95
We analyze 4563.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -440.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-440.5/100

We analyze 4563.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

4563.T struggles to generate sufficient returns from assets.

ROA > 10%
-1.06%

Valuation Score

Excellent

4563.T trades at attractive valuation levels.

PE < 25
-4.09
PEG Ratio < 2
-0.02

Growth Score

Excellent

4563.T delivers strong and consistent growth momentum.

Revenue Growth > 5%
35.94%
EPS Growth > 10%
87.92%

Financial Health Score

Weak

4563.T carries high financial risk with limited liquidity.

Debt/Equity < 1
3.52
Current Ratio > 1
0.95

Profitability Score

Weak

4563.T struggles to sustain strong margins.

ROE > 15%
-163.39%
Net Margin ≥ 15%
-4.02%
Positive Free Cash Flow
No

Key Financial Metrics

Is 4563.T Expensive or Cheap?

P/E Ratio

4563.T trades at -4.09 times earnings. This suggests potential undervaluation.

-4.09

PEG Ratio

When adjusting for growth, 4563.T's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values AnGes, Inc. at 75.35 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

75.35

EV/EBITDA

Enterprise value stands at -2.72 times EBITDA. This is generally considered low.

-2.72

How Well Does 4563.T Make Money?

Net Profit Margin

For every $100 in sales, AnGes, Inc. keeps $-4.02 as profit after all expenses.

-4.02%

Operating Margin

Core operations generate -6.22 in profit for every $100 in revenue, before interest and taxes.

-6.22%

ROE

Management delivers $-1.63 in profit for every $100 of shareholder equity.

-1.63%

ROA

AnGes, Inc. generates $-1.06 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.06%

Following the Money - Real Cash Generation

Operating Cash Flow

AnGes, Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

AnGes, Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

4563.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.09

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

75.35

vs 25 benchmark

P/S Ratio

Price to sales ratio

16.04

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

3.52

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.95

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.63

vs 25 benchmark

ROA

Return on assets percentage

-1.06

vs 25 benchmark

ROCE

Return on capital employed

-6.58

vs 25 benchmark

How 4563.T Stacks Against Its Sector Peers

Metric4563.T ValueSector AveragePerformance
P/E Ratio-4.0932.14 Better (Cheaper)
ROE-163.39%550.00% Weak
Net Margin-402.50%30133.00% Weak
Debt/Equity3.520.56 Weak (High Leverage)
Current Ratio0.955.70 Weak Liquidity
ROA-105.78%3.00% Weak

4563.T outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews AnGes, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

633.90%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

59.13%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

34.79%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ